Technovalia is a privately owned early-stage Australian biotech company dedicated to the research and development of innovative vaccines and diagnostics.
Technovalia, in partnership with several academic organisations and international companies is investing in the development of new technology platforms having the potential to significantly improve protection against a number of infectious diseases by producing safer, more stable, and more cost-effective vaccines and diagnostic tests.
Contact: info@technovalia.com
Company Details
- Employees
- 2
- Founded
- -
- Address
- Eastern Innovation Business Centre, 5a Hartnett Close,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- technovalia.com
- HQ
- Mulgrave, VIC
Technovalia Questions
Technovalia's website is technovalia.com
Technovalia's LinkedIn profile is https://au.linkedin.com/company/technovalia
Technovalia has
2 employees.
View email and phone details for 2
employees at Technovalia.
Technovalia's industry is
Biotechnology Research
Technovalia's top competitors are
Bioscript Pty Ltd,
The Melbourne Health Writer,
Tekcyte Limited,
Tissue Repair,
Imunexus Therapeutics Limited,
Uniquest,
Starpharma,
Whipbird Communications Pty Ltd,
Universal Biosensors,
Invest In Wallonia.
Technovalia's categories are Biotechnology Research
Technovalia's founding year is 2015
